Dallah Healthcare Company SJSC
SAU:4004

Watchlist Manager
Dallah Healthcare Company SJSC Logo
Dallah Healthcare Company SJSC
SAU:4004
Watchlist
Price: 162.2 SAR 0.12% Market Closed
Market Cap: 15.8B SAR
Have any thoughts about
Dallah Healthcare Company SJSC?
Write Note

Intrinsic Value

The intrinsic value of one Dallah Healthcare Company SJSC stock under the Base Case scenario is 116.29 SAR. Compared to the current market price of 162.2 SAR, Dallah Healthcare Company SJSC is Overvalued by 28%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
116.29 SAR
Overvaluation 28%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Dallah Healthcare Company SJSC

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for Dallah Healthcare Company SJSC cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about Dallah Healthcare Company SJSC?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Dallah Healthcare Company SJSC

Provide an overview of the primary business activities
of Dallah Healthcare Company SJSC.

What unique competitive advantages
does Dallah Healthcare Company SJSC hold over its rivals?

What risks and challenges
does Dallah Healthcare Company SJSC face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Dallah Healthcare Company SJSC.

Provide P/S
for Dallah Healthcare Company SJSC.

Provide P/E
for Dallah Healthcare Company SJSC.

Provide P/OCF
for Dallah Healthcare Company SJSC.

Provide P/FCFE
for Dallah Healthcare Company SJSC.

Provide P/B
for Dallah Healthcare Company SJSC.

Provide EV/S
for Dallah Healthcare Company SJSC.

Provide EV/GP
for Dallah Healthcare Company SJSC.

Provide EV/EBITDA
for Dallah Healthcare Company SJSC.

Provide EV/EBIT
for Dallah Healthcare Company SJSC.

Provide EV/OCF
for Dallah Healthcare Company SJSC.

Provide EV/FCFF
for Dallah Healthcare Company SJSC.

Provide EV/IC
for Dallah Healthcare Company SJSC.

Show me price targets
for Dallah Healthcare Company SJSC made by professional analysts.

What are the Revenue projections
for Dallah Healthcare Company SJSC?

How accurate were the past Revenue estimates
for Dallah Healthcare Company SJSC?

What are the Net Income projections
for Dallah Healthcare Company SJSC?

How accurate were the past Net Income estimates
for Dallah Healthcare Company SJSC?

What are the EPS projections
for Dallah Healthcare Company SJSC?

How accurate were the past EPS estimates
for Dallah Healthcare Company SJSC?

What are the EBIT projections
for Dallah Healthcare Company SJSC?

How accurate were the past EBIT estimates
for Dallah Healthcare Company SJSC?

Compare the revenue forecasts
for Dallah Healthcare Company SJSC with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Dallah Healthcare Company SJSC and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Dallah Healthcare Company SJSC against its competitors.

Analyze the profit margins
(gross, operating, and net) of Dallah Healthcare Company SJSC compared to its peers.

Compare the P/E ratios
of Dallah Healthcare Company SJSC against its peers.

Discuss the investment returns and shareholder value creation
comparing Dallah Healthcare Company SJSC with its peers.

Analyze the financial leverage
of Dallah Healthcare Company SJSC compared to its main competitors.

Show all profitability ratios
for Dallah Healthcare Company SJSC.

Provide ROE
for Dallah Healthcare Company SJSC.

Provide ROA
for Dallah Healthcare Company SJSC.

Provide ROIC
for Dallah Healthcare Company SJSC.

Provide ROCE
for Dallah Healthcare Company SJSC.

Provide Gross Margin
for Dallah Healthcare Company SJSC.

Provide Operating Margin
for Dallah Healthcare Company SJSC.

Provide Net Margin
for Dallah Healthcare Company SJSC.

Provide FCF Margin
for Dallah Healthcare Company SJSC.

Show all solvency ratios
for Dallah Healthcare Company SJSC.

Provide D/E Ratio
for Dallah Healthcare Company SJSC.

Provide D/A Ratio
for Dallah Healthcare Company SJSC.

Provide Interest Coverage Ratio
for Dallah Healthcare Company SJSC.

Provide Altman Z-Score Ratio
for Dallah Healthcare Company SJSC.

Provide Quick Ratio
for Dallah Healthcare Company SJSC.

Provide Current Ratio
for Dallah Healthcare Company SJSC.

Provide Cash Ratio
for Dallah Healthcare Company SJSC.

What is the historical Revenue growth
over the last 5 years for Dallah Healthcare Company SJSC?

What is the historical Net Income growth
over the last 5 years for Dallah Healthcare Company SJSC?

What is the current Free Cash Flow
of Dallah Healthcare Company SJSC?

Discuss the annual earnings per share (EPS)
trend over the past five years for Dallah Healthcare Company SJSC.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Dallah Healthcare Company SJSC

Current Assets 1.4B
Cash & Short-Term Investments 143m
Receivables 830.3m
Other Current Assets 428.4m
Non-Current Assets 5B
Long-Term Investments 1.6B
PP&E 3.2B
Intangibles 199.4m
Current Liabilities 1.2B
Accounts Payable 306.8m
Accrued Liabilities 184m
Short-Term Debt 580.9m
Other Current Liabilities 118.6m
Non-Current Liabilities 1.9B
Long-Term Debt 1.3B
Other Non-Current Liabilities 559.5m
Efficiency

Earnings Waterfall
Dallah Healthcare Company SJSC

Revenue
3.1B SAR
Cost of Revenue
-1.9B SAR
Gross Profit
1.2B SAR
Operating Expenses
-612.3m SAR
Operating Income
555.6m SAR
Other Expenses
-111.9m SAR
Net Income
443.7m SAR

Free Cash Flow Analysis
Dallah Healthcare Company SJSC

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Dallah Healthcare Company SJSC's profitability score is 57/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional 3-Years Revenue Growth
Positive Free Cash Flow
Positive Revenue Growth Forecast
57/100
Profitability
Score

Dallah Healthcare Company SJSC's profitability score is 57/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Dallah Healthcare Company SJSC's solvency score is 57/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Short-Term Solvency
57/100
Solvency
Score

Dallah Healthcare Company SJSC's solvency score is 57/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Dallah Healthcare Company SJSC

Wall Street analysts forecast Dallah Healthcare Company SJSC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Dallah Healthcare Company SJSC is 171.84 SAR with a low forecast of 141.4 SAR and a high forecast of 201.6 SAR.

Lowest
Price Target
141.4 SAR
13% Downside
Average
Price Target
171.84 SAR
6% Upside
Highest
Price Target
201.6 SAR
24% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Dallah Healthcare Company SJSC?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Dallah Healthcare Company SJSC is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Dallah Healthcare Company SJSC Logo
Dallah Healthcare Company SJSC

Country

Saudi Arabia

Industry

Health Care

Market Cap

15.8B SAR

Dividend Yield

0.62%

Description

Dallah Healthcare Co. engages in the provision and operation of healthcare programs and utilities. The company is headquartered in Riyadh, Riyadh. The company went IPO on 2012-12-16. The firm operates in the following business segments: Hospitals; Medicines, and Head Office. The Hospitals’ segment objectives are to own, manage, operate and maintain healthcare facilities. The Medicines’ segment objectives are to import, distribute, wholesale and retail medicines, as well as manufacture medicines, pharmaceuticals, herbals, health, cosmetics, detergents, disinfectants, and packaging materials. The Head Office’s segment objectives are to operate, manage and maintain healthcare facilities; wholesale and retail surgical equipment, artificial parts, handicapped and hospitals equipment, as well as other supporting services.

Contact

RIYADH
Riyadh
Nakheel Building, 1157 King Fahad Road, 2nd Floor, Nakheel District
+966112255065
www.dallahhealth.com

IPO

2012-12-16

Employees

-

Officers

See Also

Discover More
What is the Intrinsic Value of one Dallah Healthcare Company SJSC stock?

The intrinsic value of one Dallah Healthcare Company SJSC stock under the Base Case scenario is 116.29 SAR.

Is Dallah Healthcare Company SJSC stock undervalued or overvalued?

Compared to the current market price of 162.2 SAR, Dallah Healthcare Company SJSC is Overvalued by 28%.

Back to Top